Nicergoline CAS 27848-84-6 for Improved Brain Function

Product Description:

Product Name: Nicergoline CAS NO: 27848-84-6

Synonyms:

5-bromo-nicotinic acid 10-metho-xy-1,6-dimethyl-ergolin-8-ylmethyl ester;

ergoline-8-methanol 10-metho-xy-1,6-dimethyl-,8-(5-bromo-3-pyridinecarboxylate);

[(8R,10S)-10-Metho-xy-1,6-dimethylergolin-8-yl]methyl 5-Bromopyridine-3-carboxylate;

Chemical & Physical Properties:

Appearance: White or yellowish powder

Assay :≥99.00%

Density: 1.47 g/cm3

Boiling Point: 594.4℃ at 760 mmHg

Flash Point: 313.3℃

Stability: Stable at normal temperatures and pressures.

Water Solubility: Soluble in alcohol, chloroform, and ace-tone. Insoluble in water.

Storage Condition: 2-8℃

Vapor Pressure: 0mmHg at 25℃

Safety Information:

Hazard Class: 6.1(b)

Safety Statement: S36

Packing Group: III

RIDADR: UN 1544

Risk Statement: R22

Hazard Code: Xn

Nicergoline (INN, marketed under the trade name Sermion) is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It has been found to increase mental agility and enhance clarity and perception. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs.

It is used for vascular disorders such as cerebral thrombosis and atherosclerosis, arterial blockages in the limbs, Raynaud's disease, vascular migraines, and retinopathy.

Nicergoline has been registered in over fifty countries and has been used for more than three decades for the treatment of cognitive, affective, and behavioral disorders of older people.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.